13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001631134
申报总市值
US$19.3亿
US$19.3亿
58 檔
27.2%
Q3 2024 季度申报显示，Sofinnova Investments, Inc. 披露的美股组合总市值为 US$19.3亿，涵盖 58 个不同之权益投资仓位。
在 Q3 2024，Sofinnova Investments, Inc. 展现出较为审慎的避险与获利了结姿态。本季共减仓 15 个仓位并完全清仓 29 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Sofinnova Investments, Inc. 的前 5 大核心持股（包含 NTRA, VERA, NVO 等）合计占整体申报市值的 27.2%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | 股票-医疗保健 | 15.62% | +9.98% | — | |
| 2 | VERA | Vera Therapeutics Inc | 股票-其他 | 9.80% | +1.93% | — | |
| 3 | NVO | Novo-nordisk A/s-spons Adr | 股票-医疗保健 | 6.86% | — | +11.82% | |
| 4 | AZNN | Astrazeneca Plc-spons Adr | 股票-其他 | 5.00% | — | +1.00% | |
| 5 | IDYA | Ideaya Biosciences Inc | 股票-其他 | 4.40% | +0.35% | +51.92% | |
| 6 | ELAN | Elanco Animal Health Inc | 股票-医疗保健 | 4.10% | — | +22.85% | |
| 7 | BIOA | Bioage Labs Inc | 股票-其他 | 3.80% | +1.39% | — | |
| 8 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 3.78% | -0.62% | +70.71% | |
| 9 | INCY | Incyte CORP | 股票-医疗保健 | 3.75% | — | — | |
| 10 | SLNOEUR | Soleno Therapeutics Inc | 股票-其他 | 3.55% | -0.02% | EXIT | |
| 11 | RAPP | Rapport Therapeutics Inc | 股票-其他 | 3.24% | +1.84% | +2.26% | |
| 12 | AVBP | Arrivent Biopharma Inc | 股票-其他 | 3.16% | +1.56% | — | |
| 13 | YMABUSD | Y-mabs Therapeutics Inc | 股票-其他 | 2.29% | — | — | |
| 14 | DYN | Dyne Therapeutics Inc | 股票-其他 | 2.20% | +0.77% | -52.51% | |
| 15 | COGT | Cogent Biosciences Inc | 股票-其他 | 1.94% | -1.02% | -18.32% | |
| 16 | SVRA | Savara Inc | 股票-其他 | 1.91% | +0.04% | +2.79% | |
| 17 | NVS | Novartis Ag-sponsored Adr | 股票-医疗保健 | 1.83% | — | — | |
| 18 | ✓ | Inozyme Pharma Inc | 股票-其他 | 1.78% | — | — | |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 股票-医疗保健 | 1.67% | +0.25% | — | |
| 20 | INSM | Insmed Inc | 股票-医疗保健 | 1.66% | -1.28% | +25.71% | |
| 21 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 1.20% | — | -63.46% | |
| 22 | RYTM | Rhythm Pharmaceuticals Inc | 股票-其他 | 1.15% | +0.85% | — | |
| 23 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 1.06% | — | -83.43% | |
| 24 | BSX | Boston Scientific CORP | 股票-医疗保健 | 0.90% | — | -20.61% | |
| 25 | PHVS | Pharvaris N.V. | 股票-其他 | 0.88% | +0.70% | -0.20% | |
| 26 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 0.82% | +0.34% | -19.11% | |
| 27 | IMNM | Immunome Inc | 股票-其他 | 0.79% | +0.47% | +3.22% | |
| 28 | GH | Guardant Health Inc | 股票-医疗保健 | 0.74% | — | — | |
| 29 | RVMD | Revolution Medicines Inc | 股票-医疗保健 | 0.73% | — | -55.33% | |
| 30 | INBX | Inhibrx Biosciences Inc | 股票-其他 | 0.67% | +0.44% | +15.70% | |
| 31 | TGTX | Tg Therapeutics Inc | 股票-医疗保健 | 0.67% | — | -80.73% | |
| 32 | ✓ | 股票-其他 | 0.62% | — | — | ||
| 33 | ✓ | Establishment Labs Holdings In | 股票-其他 | 0.62% | -0.07% | EXIT | |
| 34 | MRNS* | Marinus Pharmaceuticals Inc | 股票-其他 | 0.61% | — | +3.05% | |
| 35 | JANX | Janux Therapeutics Inc | 股票-其他 | 0.59% | — | — | |
| 36 | CABA | Cabaletta Bio Inc | 股票-其他 | 0.57% | — | +25.69% | |
| 37 | ACHV | Achieve Life Sciences Inc | 股票-其他 | 0.57% | — | +9.05% | |
| 38 | KURA | Kura Oncology Inc | 股票-其他 | 0.46% | — | -64.02% | |
| 39 | PAHC | Phibro Animal Health Corp-a | 股票-其他 | 0.43% | — | +0.50% | |
| 40 | ILMN | Illumina Inc | 股票-医疗保健 | 0.42% | — | — | |
| 41 | ERAS | Erasca Inc | 股票-其他 | 0.40% | — | +8.42% | |
| 42 | ✓ | Immatics NV | 股票-其他 | 0.35% | +0.56% | -51.54% | |
| 43 | NARIUSD | Inari Medical Inc | 股票-其他 | 0.30% | — | -42.04% | |
| 44 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 0.29% | — | — | |
| 45 | NXTCEUR | Nextcure Inc | 股票-其他 | 0.29% | — | — | |
| 46 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 0.28% | — | — | |
| 47 | EXK | Exact Sciences CORP | 股票-原材料 | 0.20% | — | -79.30% | |
| 48 | IRON | Disc Medicine Inc | 股票-其他 | 0.16% | +0.36% | +41.35% | |
| 49 | BOLT1EUR | Bolt Biotherapeutics Inc | 股票-其他 | 0.14% | — | — | |
| 50 | GPCR | Structure Therapeutics Inc | 股票-其他 | 0.14% | — | +335.13% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | +6.9% | — | 不变 |
| 2 | VERA | Vera Therapeutics Inc | +4.6% | — | 不变 |
| 3 | BIOA | Bioage Labs Inc | +3.8% | NEW | 新建仓 |
| 4 | INCY | Incyte CORP | +3.8% | NEW | 新建仓 |
| 5 | AXSM | Axsome Therapeutics Inc | +2.5% | +70.71% | 加仓 |
| 6 | SLNOEUR | Soleno Therapeutics Inc | +2.4% | +59.89% | 加仓 |
| 7 | IDYA | Ideaya Biosciences Inc | +2.3% | +51.92% | 加仓 |
| 8 | NVO | Novo-nordisk A/s-spons Adr | +2% | +11.82% | 加仓 |
| 9 | ELAN | Elanco Animal Health Inc | +2% | +22.85% | 加仓 |
| 10 | NVS | Novartis Ag-sponsored Adr | +1.8% | NEW | 新建仓 |
| 11 | AZNN | Astrazeneca Plc-spons Adr | +1.8% | +1.00% | 加仓 |
| 12 | JAZZ | Jazz Pharmaceuticals plc | +1.7% | NEW | 新建仓 |
| 13 | AVBP | Arrivent Biopharma Inc | +1.5% | — | 不变 |
| 14 | RYTM | Rhythm Pharmaceuticals Inc | +1.2% | NEW | 新建仓 |
| 15 | YMABUSD | Y-mabs Therapeutics Inc | +0.9% | — | 不变 |
| 16 | RAPP | Rapport Therapeutics Inc | +0.9% | +2.26% | 加仓 |
| 17 | INSM | Insmed Inc | +0.9% | +25.71% | 加仓 |
| 18 | ✓ | Inozyme Pharma Inc | +0.8% | — | 不变 |
| 19 | SVRA | Savara Inc | +0.8% | +2.79% | 加仓 |
| 20 | GH | Guardant Health Inc | +0.7% | NEW | 新建仓 |
| 21 | COGT | Cogent Biosciences Inc | +0.7% | -18.32% | 减仓 |
| 22 | JANX | Janux Therapeutics Inc | +0.6% | NEW | 新建仓 |
| 23 | ILMN | Illumina Inc | +0.4% | NEW | 新建仓 |
| 24 | IMNM | Immunome Inc | +0.4% | +3.22% | 加仓 |
| 25 | EWTX | Edgewise Therapeutics Inc | +0.4% | -19.11% | 减仓 |
| 26 | MRNS* | Marinus Pharmaceuticals Inc | +0.4% | +3.05% | 加仓 |
| 27 | INBX | Inhibrx Biosciences Inc | +0.3% | +15.70% | 加仓 |
| 28 | ✓ | +0.3% | — | 不变 | |
| 29 | BDX | Becton Dickinson And Co | +0.3% | NEW | 新建仓 |
| 30 | PHVS | Pharvaris N.V. | +0.3% | -0.20% | 减仓 |
| 31 | TMO | Thermo Fisher Scientific Inc | +0.3% | NEW | 新建仓 |
| 32 | ACHV | Achieve Life Sciences Inc | +0.2% | +9.05% | 加仓 |
| 33 | BSX | Boston Scientific CORP | +0.2% | -20.61% | 减仓 |
| 34 | PAHC | Phibro Animal Health Corp-a | +0.2% | +0.50% | 加仓 |
| 35 | ERAS | Erasca Inc | +0.2% | +8.42% | 加仓 |
| 36 | GPCR | Structure Therapeutics Inc | +0.1% | +335.13% | 加仓 |
| 37 | CABA | Cabaletta Bio Inc | +0.1% | +25.69% | 加仓 |
| 38 | IRON | Disc Medicine Inc | +0.1% | +41.35% | 加仓 |
| 39 | VIR | Vir Biotechnology Inc | +0.1% | NEW | 新建仓 |
| 40 | NXTCEUR | Nextcure Inc | +0.1% | — | 不变 |
| 41 | RNAGBP | Avidity Biosciences Inc | +0.1% | +42.23% | 加仓 |
| 42 | CATX | Perspective Therapeutics Inc | +0.1% | -8.67% | 减仓 |
| 43 | REPL | Replimune Group Inc | 0% | NEW | 新建仓 |
| 44 | CATBUSD | Astria Therapeutics Inc | 0% | +41.11% | 加仓 |
| 45 | BOLT1EUR | Bolt Biotherapeutics Inc | 0% | — | 不变 |
| 46 | LUNG | Pulmonx CORP | 0% | +3.43% | 加仓 |
| 47 | ✓ | Immatics N.v | 0% | +5.11% | 加仓 |
| 48 | ✓ | Ikena Oncology Inc | 0% | — | 不变 |
| 49 | PDSB | Pds Biotechnology CORP | 0% | EXIT | 清仓 |
| 50 | KYTX | Kyverna Therapeutics Inc | 0% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Sofinnova Investments, Inc. 在 Q3 2024 季度的美股持仓总市值约为 US$19.3亿，共申报了 58 个公开持股仓位。
在 Q3 2024 季度，Sofinnova Investments, Inc. 按市值排列的前三大核心持股分别为：NTRA (15.6%)、VERA (9.8%)、NVO (6.9%)。其中最大持股仓位 NTRA 占据整体投资组合约 15.6% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
BIOA
市值: US$4794.2万
本季最大获利了结 / 清仓标的
QQQ
前期市值: US$1.9亿
在 Q3 2024 季度中，Sofinnova Investments, Inc. 共进行了 78 项持仓异动，包含新建仓 12 个仓位、加仓 22 个仓位、减仓 15 个仓位以及清仓 29 个仓位。 其中最大新建仓标的为 BIOA。 本季清仓仓位包含 QQQ。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。